Clinical & Diagnostic
On September 23, 2023, oncologists and experts from more than 60 clinical research centers across the country gathered in Guangzhou to ...
September 25, 2023 | News
In conjunction with Institut Kanser Negara's (IKN) 10th anniversary, AstraZeneca announced its collaboration to accelerate digitalisati...
September 25, 2023 | News
"We are pleased to partner with Aditum Bio, a highly innovative venture capital firm established by pharma industry leaders with deep drug development expe...
September 22, 2023 | News
"Currently, the clinical challenges from multi-drug resistant infections are severe. The recommendation of priority review by CDE for cefepime-taniborbacta...
September 20, 2023 | News
Oscotec and ADEL are jointly developing a novel disease-modifying immunotherapy agent (ADEL-Y01) targeting tau protein accumulation in the AD brain. ADEL-Y...
September 15, 2023 | News
Scientists at deCODE genetics, a subsidiary of Amgen, and their collaborators from the Icelandic healthcare system and The Copenhagen University,...
September 15, 2023 | News
"This MOU marks a key milestone for the development of genomics in South Korea as we introduce localized, high-quality and cost-effective solutio...
September 14, 2023 | News
Subject to the terms of the agreement, Astellas will receive total payments of up to €5.5 million including upfront and milestone payments. In additio...
September 13, 2023 | News
Roche Diagnostics Middle East FZCO, a global leader in diagnostics, and Burjeel Holdings, one of the largest healthcare services providers in the MENA regi...
September 11, 2023 | News
The cohort level unblinded data from the study demonstrated that in the intent to treat analysis at Week 24 (end of treatment or EoT), 26.3% (15 pa...
September 07, 2023 | News
Guangzhou Gloria Biosciences ("GloriaBio"), a commercial stage biopharmaceutical company focusing on the discovery, development and commercialization of bi...
September 07, 2023 | News
IVIS® Spectrum 2 and IVIS SpectrumCT 2imaging systems — new flagship platforms setting the standard in high-throughput performance and versat...
September 06, 2023 | News
The formal signing ceremony of the MoU was presided over by Farizal B. Jaafar, Acting Chief Executive Officer of MHTC, and Dr. Stacey Rizza, Mayo...
September 06, 2023 | News
Phase 3 innovaTV 301 confirmatory trial met its primary endpoint of improved overall survival (OS) at predetermined, independent interim analysis ...
September 05, 2023 | News
Most Read
Bio Jobs
News
Editor Picks